Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups - PubMed (original) (raw)

. 2011 Sep;63(9):2755-63.

doi: 10.1002/art.30452.

Katsue Sunahori, Jian Zhao, Yun Deng, Kenneth M Kaufman, Jennifer A Kelly, Carl D Langefeld, Adrienne H Williams, Mary E Comeau, Julie T Ziegler, Miranda C Marion, Sang-Cheol Bae, Joo Hyun Lee, Ji-Seon Lee, Deh-Ming Chang, Yeong Wook Song, Chack-Yung Yu, Robert P Kimberly, Jeffrey C Edberg, Elizabeth E Brown, Michelle A Petri, Rosalind Ramsey-Goldman, Luis M Vilá, John D Reveille, Marta E Alarcón-Riquelme, John B Harley, Susan A Boackle, Anne M Stevens, R Hal Scofield, Joan T Merrill, Barry I Freedman, Juan-Manuel Anaya, Lindsey A Criswell, Chaim O Jacob, Timothy J Vyse, Timothy B Niewold, Patrick M Gaffney, Kathy L Moser, Gary S Gilkeson, Diane L Kamen, Judith A James, Jennifer M Grossman, Bevra H Hahn, George C Tsokos, Betty P Tsao, Graciela S Alarcón; BIOLUPUS Network; GENLES Network

Collaborators, Affiliations

Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups

Wenfeng Tan et al. Arthritis Rheum. 2011 Sep.

Erratum in

Abstract

Objective: T cells from patients with systemic lupus erythematosus (SLE) express increased amounts of PP2Ac, which contributes to decreased production of interleukin-2 (IL-2). Because IL-2 is important in the regulation of several aspects of the immune response, it has been proposed that PP2Ac contributes to the expression of SLE. This study was designed to determine whether genetic variants of PPP2AC are linked to the expression of SLE and specific clinical manifestations and account for the increased expression of PP2Ac.

Methods: We conducted a trans-ethnic study of 8,695 SLE cases and 7,308 controls of 4 different ancestries. Eighteen single-nucleotide polymorphisms (SNPs) across PPP2CA were genotyped using an Illumina custom array. PPP2CA expression in SLE and control T cells was analyzed by real-time polymerase chain reaction.

Results: A 32-kb haplotype comprising multiple SNPs of PPP2CA showed significant association with SLE in Hispanic Americans, European Americans, and Asians, but not in African Americans. Conditional analyses revealed that SNP rs7704116 in intron 1 showed consistently strong association with SLE across Asian, European American, and Hispanic American populations (odds ratio 1.3 [95% confidence interval 1.14-1.31], meta-analysis P=3.8×10(-7)). In European Americans, the largest ethnic data set studied, the risk A allele of rs7704116 was associated with the presence of renal disease, anti-double-stranded DNA, and anti-RNP antibodies. PPP2CA expression was ∼2-fold higher in SLE patients carrying the rs7704116 AG genotype than those carrying the GG genotype (P=0.007).

Conclusion: Our data provide the first evidence of an association between PPP2CA polymorphisms and elevated PP2Ac transcript levels in T cells, which implicates a new molecular pathway for SLE susceptibility in European Americans, Hispanic Americans, and Asians.

Copyright © 2011 by the American College of Rheumatology.

PubMed Disclaimer

Figures

Figure 1

Figure 1

PPP2CA gene structure with tested SNPs and haplotype blocks in HA, EA, Asian and AA patients. A. The −log10 base of allelic p value for each SNP. B. PPP2CA gene structure with tested SNPs. Two SNPs (rs7704116 and rs10491322) that showed consistently strong association with SLE across Asian, EA and HA are marked with frame. C. Haplotype blocks based on 18 tested SNPs in HA, EA, Asian and AA SLE patients.

Figure 2

Figure 2

Association of PPP2CA genotypes with mRNA expression levels. Relative mRNA expression levels of PPP2CA in isolated T cells from SLE and healthy controls (HC) with the AG or GG genotype at rs7704116 (AG = 8 vs. GG = 21 in SLE and AG = 8 vs. GG = 9 in healthy controls) were determined by real-time PCR and normalized to GAPDH. Relative mRNA expression levels were log 10 transformed to normalize its distribution. The results represent the mean±SD of four independent experiments. None of the subjects were homozygous for the minor A allele.

Similar articles

Cited by

References

    1. Eichhorn PJ, Creyghton MP, Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta. 2009;1795(1):1–15. - PubMed
    1. Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J. 2001;353(Pt 3):417–39. - PMC - PubMed
    1. Roberts KG, Smith AM, McDougall F, Carpenter H, Horan M, Neviani P, et al. Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers. Cancer Res. 2010;70(13):5438–47. - PMC - PubMed
    1. Purev E, Giordano A, Soprano DR, Soprano KJ. Interaction of PP2A catalytic subunit with Rb2/p130 is required for all-trans retinoic acid suppression of ovarian carcinoma cell growth. J Cell Physiol. 2006;206(2):495–502. - PubMed
    1. Shi Y. Serine/threonine phosphatases: mechanism through structure. Cell. 2009;139(3):468–84. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources